Varsha Tembe

Varsha Tembe

UNVERIFIED PROFILE

Are you Varsha Tembe?   Register this Author

Register author
Varsha Tembe

Varsha Tembe

Publications by authors named "Varsha Tembe"

Are you Varsha Tembe?   Register this Author

18Publications

713Reads

32Profile Views

Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.

J Invest Dermatol 2016 Jan;136(1):245-254

School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/JID.2015.355DOI Listing
January 2016

Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes.

Pathology 2015 Dec;47(7):683-93

1Melanoma Institute Australia, North Sydney, NSW 2Sydney Medical School, The University of Sydney, Camperdown, NSW 3Immunogenomics Laboratory, Australian National University, Canberra, ACT 4Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Qld 5Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW 6Bioplatforms Australia, Macquarie University, North Ryde, NSW 7Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic 8The Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Vic 9Departments of Melanoma and Surgical Oncology 10Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; these authors contributed equally.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000324DOI Listing
December 2015

The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.

Cell Signal 2015 Sep 3;27(9):1763-71. Epub 2015 Jun 3.

Centre for Cancer Research, The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2015.05.011DOI Listing
September 2015

MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.

Pigment Cell Melanoma Res 2015 May 5;28(3):254-66. Epub 2015 Jan 5.

Westmead Millennium Institute, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12343DOI Listing
May 2015

Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.

Nat Commun 2014 Dec 2;5:5694. Epub 2014 Dec 2.

1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6694DOI Listing
December 2014

Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking BRAF inhibitors.

Pigment Cell Melanoma Res 2012 Sep 6;25(5):569-72. Epub 2012 Aug 6.

Department of Dermatology, Westmead Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1755-148X.2012.01031.xDOI Listing
September 2012

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.

Mol Cancer Ther 2012 Apr 1;11(4):888-97. Epub 2012 Mar 1.

Queensland Institute of Medical Research, Oncogenomics Laboratory, Queensland University of Technology, Brisbane, Queensland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-11-0676DOI Listing
April 2012

BARD1 translocation to mitochondria correlates with Bax oligomerization, loss of mitochondrial membrane potential, and apoptosis.

J Biol Chem 2007 Jul 17;282(28):20513-22. Epub 2007 May 17.

Westmead Institute for Cancer Research, University of Sydney, Westmead Millennium Institute at Westmead Hospital, Westmead, New South Wales 2145, Australia.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M702627200
Publisher Site
http://dx.doi.org/10.1074/jbc.M702627200DOI Listing
July 2007

Protein trafficking in response to DNA damage.

Cell Signal 2007 Jun 15;19(6):1113-20. Epub 2007 Mar 15.

Westmead Institute for Cancer Research, Westmead Millennium Institute at Westmead Hospital, University of Sydney, NSW 2145, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2007.03.001DOI Listing
June 2007

Nuclear targeting and cell cycle regulatory function of human BARD1.

J Biol Chem 2005 Mar 4;280(10):8855-61. Epub 2005 Jan 4.

Westmead Institute for Cancer Research, University of Sydney, Westmead Millennium Institute at Westmead Hospital, Darcy Road, PO Box 412, Westmead, Sydney, New South Wales 2145, Australia.

View Article

Download full-text PDF

Source
http://www.jbc.org/content/early/2005/01/04/jbc.M413741200.f
Web Search
http://www.jbc.org/cgi/doi/10.1074/jbc.M413741200
Publisher Site
http://dx.doi.org/10.1074/jbc.M413741200DOI Listing
March 2005

Issues arising from the prenatal diagnosis of some rare trisomy mosaics--the importance of cryptic fetal mosaicism.

Prenat Diagn 2004 Jul;24(7):524-36

Department of Cytogenetics, Western Sydney Genetics Program, The Children's Hospital at Westmead, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pd.936DOI Listing
July 2004